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Summary
Regulatory T-cell (Treg, CD4+CD25+) dysfunction is suspected to
play a key role in immune senescence and contributes to
increased susceptibility to diseases with age by suppressing
T-cell responses. FoxP3 is a master regulator of Treg function, and
its expression is under control of several epigenetically labile
promoters and enhancers. Demethylation of CpG sites within
these regions is associated with increased FoxP3 expression and
development of a suppressive phenotype. We examined differ-
ences in FoxP3 expression between young (3–4 months) and
aged (18–20 months) C57BL/6 mice. DNA from CD4+ T cells is
hypomethylated in aged mice, which also exhibit increased Treg
numbers and FoxP3 expression. Additionally, Treg from aged
mice also have greater ability to suppress effector T-cell (Teff)
proliferation in vitro than Tregs from young mice. Tregs from
aged mice exhibit greater redox remodeling–mediated suppres-
sion of Teff proliferation during coculture with DCs by decreasing
extracellular cysteine availability to a greater extent than Tregs
from young mice, creating an adverse environment for Teff
proliferation. Tregs from aged mice produce higher IL-10 levels
and suppress CD86 expression on DCs more strongly than Tregs
from young mice, suggesting decreased T-cell activity. Taken
together, these results reveal a potential mechanism of higher
Treg-mediated activity that may contribute to increased immune
suppression with age.
Key words: aging; epigenetics; methylation; redox; regula-
tory T cell.
Introduction
It is generally accepted that aging is associated with altered immune
response including decay in Th1-Th2-mediated immunity, diminished
na€ıve T-cell-mediated de novo responses and an altered memory T-cell
compartment (Raynor et al., 2012). Consequently, immune senescence
is associated with higher susceptibility to infections, autoimmunity, and
cancer in the elderly (Richardson, 2002; Mendez et al., 2004; Sharma
et al., 2006). Moreover, while aging has been reported to be associated
with increased regulatory T-cell (Treg, CD4+ CD25+) numbers, there is
little information about its functional consequences on immune
suppression.
Tregs can be defined by the expression of the forkhead/winged-helix
family of transcription factor (FoxP3) that is both necessary and sufficient
for Treg development (Hori et al., 2003). Two major populations of
Tregs exist: the so-called natural (nTreg) and inducible (iTreg) Tregs.
nTregs are produced in the thymus, while iTregs differentiate extrathy-
mically in secondary lymphoid organs in response to antigen exposure
(Huehn et al., 2009). Tregs maintain peripheral tolerance and keep
autoreactive cells at bay. However, excess Treg activity may lead to
increased susceptibility to infection, neurodegenerative diseases, and
cancer (Richardson, 2002; Mendez et al., 2004; Sharma et al., 2006).
Although recent studies have shown that aging is associated with
increased Treg numbers, the underlying mechanism of this phenomenon
is unknown. One potential mechanism might be age-related alteration in
epigenetic programming affecting Tregs. Epigenetic regulation of gene
expression occurs via chemical modifications, such as histone acetylation
and methylation, without alterations in the nucleotide sequence in the
genome (Delaney et al., 2012). DNA methylation is associated with gene
silencing, while demethylation promotes gene expression. T-cell DNA is
hypomethylated in older relative to young individuals (Agrawal et al.,
2010). The FoxP3 locus possesses several epigenetically labile regulatory
regions which are differentially methylated in subsets of CD4+ cells
(Huehn et al., 2009). For example, it is known that na€ıve CD4+CD25
T cells, activated CD4+ cells, and TGF-b-induced Treg cells are methy-
lated at CpG dinucleotides upstream of the FoxP3 enhancer but
demethylated in nTregs (Lal & Bromberg, 2009). However, it is not
known whether a differential methylation pattern exists at the FoxP3
locus between young and old mice as a potential mechanism underlying
higher Treg expression.
Induction of optimal effector T-cell (Teff) responses depends on their
interaction with costimulatory molecules (e.g., CD80/86) on dendritic
cells (DCs). Tregs suppress DC activity by downregulating these
molecules (Cederbom et al., 2000). Tregs diminish the ability of
antigen-presenting cells (APCs) including DCs to form stable contacts
with responding T cells, thereby interfering with T-cell activation.
Recently, it was shown that DCs from older mice express lower CD86
in vivo relative to DCs from younger mice (Chiu et al., 2007). However, it
is unknown whether this lower CD86 expression is due to age-associated
decline or if Tregs from aged animal have greater capacity to
downregulate CD86 expression or both.
In addition to the classical T-cell activation pathway involving TCR-
antigen-MHC II interaction, costimulatory and cytokines signals, it was
recently shown that T-cell activation and proliferation is dependent on a
DC-mediated provision of a reducing extracellular microenvironment
(Yan et al., 2009). DC/T-cell interactions induce cystine uptake in DCs via
the xc- cystine transporter. DCs uptake cystine for intracellular glutathi-
one (GSH) biosynthesis, and they provide extracellular cysteine that shifts
the redox potential in the reducing direction, which is favorable for T-cell
proliferation (Yan et al., 2009; Yan & Banerjee, 2010). As na€ıve T cells
are unable to efficiently transport cysteine, the extracellular cysteine
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made available by DCs is essential for supporting GSH synthesis (Garg
et al., 2011) which is essential for cell cycle progression (Messina &
Lawrence, 1989; Suthanthiran et al., 1990), cytotoxic T-cell activity
(Grimble, 2006), and T-cell signal transduction (Staal, 1998). Hence, by
modulating extracellular cysteine levels, DCs support intracellular GSH
synthesis in T cells and adjust the redox potential to favor T-cell activation
and proliferation (Yan & Banerjee, 2010). Large increases in nonprotein
thiols in lymphoid tissues have been observed following immunization
(Castellani et al., 2008), demonstrating the physiological relevance of
the redox microenvironment in immune function. Tregs interfere with
this process by suppressing extracellular cysteine accumulation leading in
turn to the suppression of T-cell activation and proliferation (Yan et al.,
2009). The differential ability of Tregs from young vs. old mice to
suppress the immune response by influencing the extracellular redox
potential is not known.
In this study, we confirm that aged mice have higher levels of Tregs
compared with young mice. The higher Treg numbers are associated
with hypomethylation of the upstream FoxP3 enhancer, resulting in
higher FoxP3 mRNA and protein level. We also demonstrate that Tregs
from old mice produce more IL-10, downregulate the expression of the
costimulatory CD86 on DCs, perturb the redox-mediated microenviron-
ment and cause greater suppression of T-cell proliferation in comparison
with Treg from young mice. To our knowledge, this is the first study
reporting differences in Treg activity between young and old mice and
offers a potential mechanism by which Treg activity contributes to
immune senescence in old age.
Experimental procedures
Mice
Male young adult mice (3–4 months) were purchased from Harlan
Laboratories (Indianapolis, IN, USA), while old (18–20 months) C57BL/6
mice were purchased from the National Institute on Aging (NIA). After
arrival, animals were put on an ad libitum diet for at least 1 week prior to
experiments. All mice were maintained in a pathogen-free environment
provided by the Unit for Laboratory Medicine (ULAM) at the University of
Michigan. Procedures involving the animals and their care were
approved by the Committee on the Use and Care of Animals (UCUCA)
at the University of Michigan Medical School.
Cell preparation
(i) DC isolation and differentiation-bone marrow cells from C57BL/6
mice were depleted of red blood cells and plated at 2 9 106 cells mL1
for 7 days in DC medium (DMEM supplemented with 100 lg mL1
penicillin and streptomycin, 2 mM L-glutamine, 50 lM 2-mercaptoethanol
(2-ME), 1 mM pyruvate, 1:100 nonessential amino acids, and 10%
heat-inactivated fetal bovine serum) containing recombinant murine
rGM-CSF (20 ng mL1, R&D Systems, Minnneapolis, MN, USA) and rIL-4
(20 ng mL1, R&D Systems) (Yan et al., 2009). Culture medium was
changed, and floating cells were discarded every 2 days. To check the
purity of DCs, cells were labeled with anti-CD11c (1:1000 dilution)
monoclonal antibodies (BD). The population of antibody-positive cells
under FACS was estimated to be ≥ 85% (data not shown). Immature
bone marrow–derived DCs were harvested at day 7 and used as APCs in
the coculture experiments with T cells; (ii) T-cell purification-CD3+,
CD4+, CD4+ CD25 (Teff) and CD4+ CD25+ (Treg) T cells were isolated
using the MACS microbeads technology (Miltenyi Biotec, Auburn, CA,
USA) from the spleen and lymph node (LN) using negative and/or
positive selection, according to the manufacturer’s instructions. Purity of
the isolated cells was assessed by flow cytometric analysis by staining
with FITC-conjugated anti-CD3 or PE-Cy5 anti-CD4 or isotype rat
IgG2bAbs or rat IgG2a, respectively (BD). CD3+, CD4+, and Teff purity
was consistently above 90%. Treg purity was between 80–90%.
Isolated T cells were used either for in vitro coculture experiments,
surface staining, protein or nucleic acid isolation as described below.
Culture conditions
Dendritic cells (1 9 105/well) were cocultured in 48-well plates with or
without Teff cells at 1:4 ratio in the presence or absence of Treg cells at
1:4:2 and 1:4:4 (DC/Teff/Treg) ratio for up to 72 h at 37 °C in a 5% CO2
incubator in T-cell medium (RPMI medium supplemented with
100 lg mL1 penicillin and streptomycin, 2 mM L-glutamine, 50 lM
2-mercaptoethanol and 2.5% heat-inactivated fetal bovine serum) in
the presence of plate-bound anti-CD3 antibody (1 lg mL1, BD). At
indicated time points (24, 72 h), aliquots of conditioned media were
collected for extracellular thiol measurement by HPLC. Cells were
harvested at 72 h for intracellular GSH measurement and Western blot
analysis.
Metabolite analysis
To measure extracellular thiols (cysteine and cystine), aliquots of culture
supernatants were mixed with an equal volume of metaphosphoric acid
solution (16.8 mg mL1 HPO3, 2 mg mL1 EDTA and 9 mg mL1 NaCl)
and vortexed. Proteins were sedimented by centrifugation at
~14 000 9 g for 10 min at 4 °C. Metabolites in protein-free extracts
were derivatized with monoiodoacetic acid (7 mM) followed by mixing
with an equal volume of 2,4-dinitrofluorobenzene solution (1.5% v/v in
absolute ethanol). Samples were separated by HPLC using u-Bondapak-
NH2 300 9 3.9 mm column (Waters) with a methanol/acetate gradient
and the cysteine and cystine peak was collected as described previously
(Garg et al., 2008). The concentration of individual thiols was deter-
mined by comparing the integrated peak areas with standard curves for
each compound. The contribution of metabolites in media blank was
subtracted from the final values. To measure the concentration of
intracellular GSH, cultured cells were washed with ice-cold PBS and
harvested in PBS (50 lL). An aliquot of the cell suspension in PBS was
mixed with an equal volume of metaphosphoric acid, vortexed, followed
by monoiodoacetic acid derivatization, 2,4-dinitrofluorobenzene reac-
tion and HPLC as described previously. Intracellular GSH concentrations
were normalized to total protein concentration in each sample (Garg
et al., 2006).
Global methylation analysis
Flow cytometric measurement of global methylation was performed as
described previously (Delaney et al., 2012). Briefly, 2.5 9 105 freshly
harvested T cells were stained with FITC anti-CD3 Abs and PE-Cy5 anti-
CD4, or isotypes, then fixed in Cytofix/Cytoperm (BD) and permeabilized
using PBS supplemented with 0.1% saponin, 1% FBS, and 0.1% sodium
azide. Cells were treated with RNase A to eliminate the potential for the
detection of 5-methylcytidine in tRNA. Cells were treated with anti-
5-methylcytidine (Acris Antibodies, San Diego, CA, USA), washed, then
incubated with Anti-mouse IgG1-PE or isotype rat-IgG1j (BD). Flow
cytometry was performed immediately or within 24 h of permeabiliza-
tion using a FACScaliber machine (BD). Results were analyzed with FCS
Express software (DE NOVO Software, Los Angeles, CA, USA).
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Regulatory T-cell (Treg) staining
Freshly isolated splenocytes were stained with PE-Cy5 anti-CD4 and
PE-anti-CD25 or isotypes rat IgG2a,j and rat IgM,j, respectively, for
10 min at 4 °C (BD). Cells were then fixed and permeabilized using the
Mouse FoxP3 Buffer Set and then incubated with Alexa Fluor 488 anti-
FoxP3 or isotype rat IgG2baccording to manufacturer’s instructions (BD).
Flow cytometry was performed immediately or within 24 h of permea-
bilization using a FACScaliber machine. 1 9 105 gated events were
recorded. Results were analyzed with FCS Express software.
Nucleic acid isolation
Total RNA was isolated from freshly isolated splenic T cells using RNeasy
technology (Qiagen, Valencia, CA, USA) according to the manufacturer’s
instructions. CarryoverDNAcontaminantswere removedusing theRNase-
Free DNase Set. Genomic DNA was isolated using GenElute Mammalian
Genomic DNAMiniprep Kit (Sigma, St. Louis,MO, USA). IsolatedDNA and
RNA were quantified using the NanoDrop spectrophotometer.
Bisulfite treatment of T-cell genomic DNA and
pyrosequencing of FoxP3 promoter and enhancer regions-
Sodium bisulfite treatment of 1 lg genomic DNA was performed with
the EZ DNA Methylation Gold Kit (Zymo Research, Irvine, CA, USA)
following the manufacturer’s instructions. After purification, the bisul-
fite-treated DNA was stored at 20 °C. Pyrosequencing assays were
designed using PSQ Assay Design Software (Biotage, Charlotte, NC,
USA). PCR conditions were 95 °C for 15 min, then 55 cycles of 95 °C for
15 s, 60 °C for 15 s, and 72 °C for 30 s using the Pyromark PCR kit
(Qiagen). Unmodified and biotinylated primers were used at a final
concentration of 0.2 lM and 0.1 lM, respectively. The biotinylated
strands of the amplicon were purified using streptavidin–Sepharose
beads (GE). We used reaction PyroGold reagents and manufacturer’s
recommended conditions on the Pyromark MD platform using Pyro CpG
software (Biotage). Primer sequences: FoxP3 proximal promoter Forward
5′-TTTTGTGGTGAGGG GAAGAA–3′ Reverse 5′–BIOTIN-ACCCTCA
ATACCTCTCTACCACTT–3′ Sequencing primer 5′– AAAATTGGATTA
TTAGAAG– 3′; FoxP3 upstream enhancer Forward 5′–BIOTIN-
AATGTGGGTATTAGGTAAAATTTTT–3′ Reverse and sequencing primer
B 5′– AACCCTAAAACTACCTCTAAC–3′ Sequencing primer A 5′–AAA
ACTTTTCCCAAACCCTCTC –3′.
Western Blot analysis
T cells were separated from adherent DCs from the coculture wells by
gentle pipetting andwashingwith PBS. Cells werewashed two times with
cold PBS and lysed by suspending in lysis buffer as described previously
(Garg et al., 2006). FoxP3 (Abcam, Cambridge, MA, USA), CD86 and
CD80 (R&D systems) andactin (SantaCruz Biotechnology,Dallas, TX, USA)
levels in cell extracts were detected using the respective primary and
secondary antibodies and detected using the chemiluminescent horserad-
ish peroxidase system (Pierce, Rockford, IL, USA) as described previously
(Garg et al., 2006). The intensity of protein bandswas quantifiedusing the
Image J software and normalized to the actin level in the same sample.
Alpha-ELISA
Tregs from young and old mice were cocultured with DC and Teff in
1:4:2 and 1:4:4 (DC/Teff/Treg) ratios in the presence of anti-CD3
antibody for 72 h. In a separate experiment, Treg from young and old
mice were cocultured with Teff from young and old mice at 1:1 ratio in
the presence of plate-bound anti-CD3 (1 lg mL1) and soluble
anti-CD28 antibody (1 lg mL1, BD). After 72 h, conditioned media
were collected, and IL-10 concentration was measured by using alpha-
ELISA (Perkin Elmer, Waltham, MA, USA) as per manufacturer’s
instructions.
In vitro suppression assay
CD4+ CD25+ Treg cells and CD4+ CD25 Teff cells were isolated first
using EasySep Mouse CD4+ T-Cell Isolation Kit (Stem Cell), then enriched
cells were labeled with PE-Cy5-anti-CD4 and PE-anti-CD25 (BD) and flow
sorted on a FACS Vantage (BD). Dendritic cells (DCs) were generated
from bone marrow (BM) from either syngeneic (C57BL/6) or allogeneic
(BALB/C) mouse strain as previously described (Yan et al., 2009). CD11c+
DCs from both conditions were purified with mouse CD11c MicroBeads
Kit as per manufacturer instructions (Miltenyi biotec). Of 4 9 104 Teff
cells from 3–4 months old wild-type C57BL/6 were incubated in the
indicated ratios in the T-cell media with Tregs from young and old mice
in the presence of 5 9 103 CD11c+ DCs for ~5 days in round bottom
96-well plates. Media were supplemented with 1 lg mL1 anti-CD3e
(BD) when coculturing syngeneic BM-derived and splenic DCs. Anti-IL10
neutralization antibodies or N-acetyl cysteine (NAC), when used, was
administered as a bolus to a final concentration of 10 lg mL1 or 2 mM,
respectively, at the start of coculture. Incorporation of 3H-thymidine
(1 lCi/well, Perkin Elmer) by proliferating cells was measured during the
last 18 h of culture.
Statistical analysis
Mean and SEM were calculated using Microsoft Excel application
software. Statistical significance was determined using one-tailed
Student’s t-test for single comparison. P values of < 0.05 were
considered significant.
Results
T cells from old mice are hypomethylated relative to T cells
from young mice
T cell’s DNA from aged individuals are hypo-methylated relative to T cells
fromyoung individuals (Agrawalet al., 2010). To validateprevious studies,
we compared the methylation status of T cells from older and younger
mice via an unbiased antibody-based flow cytometric method (Delaney
et al., 2012). As expected, T cells from older mice had significantly
lower methylation relative to T cells from younger mice. CD3+ and CD4+
T cells from old mice showed ~20% and ~25% lower levels of DNA
methylation, respectively, in comparison with young mice (Fig. 1A–B).
Regulatory T-cell number and FoxP3 expression is higher in
older mice relative to younger mice-
We compared the number of CD4+ CD25+ FoxP3+ Treg cells between
young and old mice by FACS analysis. Older mice had ~30% higher
Tregs as a proportion of total CD4 cells relative to young mice (Fig. 1C).
We interrogated if higher Treg number could be explained by differences
in FoxP3 expression between young and aged mice. FoxP3 mRNA was
~450% higher and protein was ~45% higher in old CD4+ T cells relative
to young CD4+ T cells (Fig. 1D, E).
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FoxP3 enhancer but not promoter is hypomethylated in older
mice
Several enhancer and promoter regions have been associated with
regulation of FoxP3 expression, and de-methylation of the CpG sites
within these regions is linked to increase FoxP3 expression coupled with
acquisition of a suppressive phenotype (Lal & Bromberg, 2009). To assess
whether differences in FoxP3 expression in aged animals could be
explained by a differential methylation status of FoxP3 enhancer and/or
promoter regions, we performed pyrosequencing across these regions.
As shown in Fig. 2A, while the methylation status of the proximal
promoter showed no difference, the enhancer methylation status at all
the interrogated sites is lower in old CD3+ T cells with a 26% mean
reduction in comparison with young mice (Fig. 2B).
Treg from aged mice exhibit greater suppression of Teff
proliferation in vitro
Higher FoxP3 expression would be expected to lead to higher Treg
activity. To check the functional consequence of higher Treg levels on
Treg-mediated suppression of Teff proliferation, we performed a series
of in vitro suppression assays. We cultured Tregs from young or old mice
with wild-type BL6 Teffs in the presence of allogeneic or syngeneic
BMDCs. Treg from old mice exhibited greater suppression of Teff
proliferation than Tregs from young mice (Fig. 3A, B). To verify the role
of IL-10 or redox mechanism in Treg-mediated suppression of Teff
proliferation, we performed the suppression assay in the presence and
absence of either anti-IL10-neutrilizing antibodies or NAC. As shown in
the Fig. 3C, both anti-IL10 antibodies and NAC reduces the Treg-
mediated suppression by young and old Tregs. We also observed an
elimination of greater suppressive capacity of old Treg by both the
molecules. The effects of NAC or anti-IL10 antibodies were dose-
dependent (data not shown).
Treg from aged mice exhibit greater redox microenvironment
perturbation
There are several mechanisms by which Tregs are believed to act to
suppress the proliferation of Teff cells. Disruption of redox remodeling by
DCs is one mechanism by which Tregs suppress Teff proliferation (Yan
et al., 2009, 2010). The cysteine/cystine redox potential is a key
determinant of the extracellular redox poise (Yan & Banerjee, 2010).
Hence, we measured extracellular cystine consumption and cysteine
accumulation at two time points (Fig. 4). As expected, conditioned
media had higher levels of cysteine when DCs were cocultured with
Teffs than cultured alone. The extracellular cysteine concentration
decreased in the presence of Tregs (Fig. 4A). When we compared the
levels of extracellular cysteine in the presence of Tregs, we found that
Tregs from aged mice exhibited greater suppression of cysteine
accumulation in a time and DC/Teff/Treg ratio dependent manner
(Fig. 4A). The level of extracellular cysteine was ~15% lower in the
presence of Tregs from old mice vs. younger mice after 72 h.
Extracellular cysteine is derived from cysteine consumed from the culture
medium, which is subsequently converted by DCs to GSH, then extruded
and hydrolyzed to its component amino acids. The resulting cysteine is
taken up by activated Teffs (Yan & Banerjee, 2010). In fact, greater
inhibition of cysteine accumulation by Tregs from old mice was
accompanied with lower cystine consumption from the media (Fig. 4B).
(A) (B)
(D)
(E)
(C)
Fig. 1 Global T-cell methylation decreases and FoxP3 expression increases
during normal aging. Resting CD3+ T cells (A) or CD4+ cells (B) isolated from young
(6–8 week) and old (18–20 week) mice were stained with antimethylcytidine
antibody and subjected to FACS analysis. Resting CD4+ T cells from young and old
mice were harvested. (C) Cells were stained with anti-CD4, anti-CD25, anti-FoxP3
antibody and subjected to FACS analysis. (D) Total RNA was isolated and FoxP3
mRNA was measured via real-time qPCR. (E) Cytoplasmic proteins were used to
measure the level of FoxP3 protein via Western blot analysis and normalized to the
level of actin in that sample. Results are mean  SEM of four experiments, each
experiment using cells pooled from at least three animals per age group;
*P < 0.05, **P < 0.01.
(A)
(B)
Fig. 2 FoxP3 enhancer is hypomethylated during normal aging process. gDNA
from CD4+ T cells were isolated and of FoxP3 enhancer (A) and promoter (B)
regions were subjected to methylation analysis via pyrosequencing as described in
Methods. Results are mean  SEM of 4 independent experiments, each
experiment using cells pooled from at least three animals per age group;
*P < 0.05.
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(A)
(C)
(B)
Fig. 3 Tregs from aged mice exhibit
greater suppression of Teff proliferation in
vitro. Flow sorted CD4+ CD25+ Treg cells
were incubated with CD4+ CD25 Teff cells
and either CD11c+ allogeneic (A) or
syngeneic (B) BMDC at indicated ratios for
~5 days in round bottom 96-well plates.
Media were supplemented with 1 lg mL1
anti- CD3e (BD) when coculturing
syngeneic BMDC. (C) To confirm the role of
IL-10 or redox metabolites in Treg-mediated
suppression of Teff proliferation, Treg were
incubated with Teff cells at a 1:1 ratio in the
presence of DCs. Anti-IL10 antibodies or
N-acetyl cysteine (NAC), when used, were
administered as a bolus at a final
concentration of 10 lg mL1 or 2 mM
respectively. Prior to harvesting, cells were
incubated overnight in the presence of 3-H
thymidine, and incorporation of
radioactivity was measured. Results are
mean  SEM and are representative of
three (syngeneic) or two (allogeneic)
experiments performed in quadruplet, each
experiment using cells pooled from at least
three animals per age group.
(A) (B)
(C) (D)
Fig. 4 Tregs from aged mice differentially
perturb the extracellular redox
microenvironment. DCs were cocultured
with Teff cells in the absence or presence of
Tregs from young or aged mice. Cysteine
(A) and cystine (B) concentrations in the
conditioned media were quantified via
HPLC, and the redox potential (C) was
calculated using the Nernst equation
(Eh = Eo + RT/2F ln [(cystine)/(cysteine)2],
using Eo = 250 mV (pH = 7.4). T cells
were separated after 72 h of coculture by
gentle washing with PBS and used for
intracellular GSH analysis (D) by HPLC. GSH
levels were normalized to protein
concentrations in each sample. Results
represent the mean  SEM and are
representative of four experiments
performed in triplicate, each experiment
using cells pooled from at least three
animals per age group; *P < 0.05.
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The extracellular redox potential is estimated to be about 80 mV for
DC cultured alone, which is associated with growth arrest and
differentiation (Yan et al., 2009). We measured a redox potential of
85 mV in DC conditioned media after 72 h of culture. Coculture of
DCs with Teff cells lowered the redox potential to 130 mV, but in the
presence of young Tregs, the redox potential increased to 120 mV. In
contrast, Tregs from old mice showed a further increase in the
extracellular redox potential to 108 mV (Fig. 4C). The shift in redox
potential in the oxidative direction is expected to be less conducive for
Teff proliferation (Yan & Banerjee, 2010).
Extracellular cysteine is a limiting substrate for GSH biosynthesis,
which is essential for T-cell proliferation (Yan et al., 2010). One of the
expected consequences of lower extracellular cysteine levels is reduced
intracellular GSH level in T cells, and indeed, Teffs exhibited lower
intracellular GSH levels in the presence of Tregs. This inhibition was even
greater when T cells were cocultured with Treg from old mice relative to
cocultures with young Tregs (Fig. 4D).
Tregs from aged mice accumulate higher IL-10 levels
Tregs control Teff cells in both a contact-dependent and contact-
independent manner using cytokines such as IL-10, TGF-b, or IL-35
(Vignali et al., 2008). To assess whether observed higher suppression by
Tregs from old mice is accompanied with higher IL-10 release, we
measured the IL-10 concentration in conditioned media. Treg from old
mice, when cocultured with DC and Teff cells, produced 100 and 47%
more IL-10 in the conditioned media at 1:4:2 and 1:4:4 ratios,
respectively, relative to Tregs from young mice (Fig. 5A). To rule out a
potentially confounding influence of DCs, we cocultured the Treg from
young and old mice with Teffs from young and old mice in the presence
of plate-bound anti-CD3 and soluble anti-CD28 and checked the
concentration of IL-10 in the conditioned media. Although IL-10 levels
were increased when young or old Teff were cocultured with Treg from
young mice, the IL-10 levels were significantly higher when the Teffs cells
were cocultured with old Tregs (Fig. 5B), suggesting greater suppressive
function in old Tregs compared with their young counterparts.
Tregs from aged mice exerts higher suppression of CD86 on
DCs
Tregs downregulate the expression of the costimulatory molecule CD86
on DCs (Cederbom et al., 2000). Suppressing CD86 expression interferes
with the interaction between CD28 (on Teff cells) and CD86 (on DCs),
directing T cells toward a hyporeactive state. While Tregs from neither
age group had an effect on the expression of CD80 on DCs, Tregs from
aged mice lowered CD86 expression ~40% more than Tregs from young
mice (Fig. 6A,B).
Discussion
Tregs exert their suppressive effects through multiple mechanisms, some
that are contact-dependent and others that are contact-independent
(Vignali et al., 2008).
Using transwell dual chamber assays, Thornton and Shevach showed
that physically separated Tregs were unable to suppress Teff proliferation
(Thornton & Shevach, 1998). However, suppressive cytokine release of
IL-10 (Roncarolo et al., 2006), TGF-b (Coffman et al., 2009), and IL-35
(Collison et al., 2007), as well as IL-2 depletion (Thornton & Shevach,
1998; Pandiyan et al., 2007), have been shown to mediate suppression
of Teffs without direct contact. Further, Tregs are known to suppress
proliferation by interacting with APCs, interfering with costimulatory
signals (Cederbom et al., 2000; Misra et al., 2004; Tang et al., 2006) or
depleting metabolites (Fallarino et al., 2003; Yan et al., 2010). We have
investigated several mechanisms of Treg-mediated suppression within
the context of aging. We report that aged Tregs suppress proliferation
more effectively via several distinct mechanisms. Tregs from aged mice,
(A) (B)
Fig. 5 Old Tregs produce higher IL-10 in the conditioned media relative to young
Tregs. (A) Treg from young and old mice were cocultured with DC and Teff as
1:4:2 and 1:4:4 (DC/Teff/Treg) ratio in the presence of anti-CD3 antibody for 72 h.
(B) Treg from young and old mice were cocultured with Teff from young and old
mice at 1:1 ratio in the presence of plate-bound anti-CD3 and soluble anti-CD28
antibody. After 72 h, conditioned media were collected, and IL-10 concentration
was measured. Results are mean  SEM and are representative of two
independent experiments performed in triplicates. Y = young Tregs, O = old
Tregs. Each experiment used cells pooled from at least three animals per age
group; *P < 0.05, ***P < 0.001.
(A) (B)
Fig. 6 Old Treg exerts higher suppression
of CD86 on DCs relative to young Treg. (A)
DCs were cocultured with Tregs at 1:4 ratio
from young or aged mice for 72 h. Cells
were harvested to check the expression of
CD86, CD80 on DCs via Western analysis.
(B) show the quantification of CD86 and
CD80 which is normalized to actin. Results
are mean  SEM and are representative of
two independent experiments, each
experiment using cells pooled from at least
three animals per age group; **P < 0.01,
***P < 0.001, n.s. = not significant.
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as compared to young mice, release more IL-10, are more effective at
downregulating CD86 expression in DCs, and modulate both the
extracellular redox environment and intracellular GSH concentration in
Teffs, creating conditions that are less favorable to proliferation
(Supplementary Fig. S1).
Treg populations increase with aging as a percentage of total T cells
(Gregg et al., 2005). In BALB/c mice, this increase in Tregs induces
tolerance to certain cancers and that cytotoxic anti-tumor activity can be
restored in vivo via depletion of Tregs (Sharma et al., 2006). We
confirmed previous studies by showing a significant increase in Tregs in
aged mice relative to controls. The so-called ‘inflamm-aging’ hypothesis
to explain why Treg numbers increase with aging invokes an interplay
between low-grade inflammation over time and an increase in oxidative
stress with the development of chronic degenerative conditions like
atherosclerosis, diabetes, and obesity (Cannizzo et al., 2011). Given the
higher levels of inflammatory signals in aging organisms, more Tregs
may be necessary to suppress this positive feedback loop of inflamma-
tion and disease progression.
Aging is also associated with T-cell’s DNA hypomethylation, an
observation that we have confirmed in our study. Lower T-cell DNA
methylation is a hallmark of several diseases including systemic lupus
erythmatosis and rheumatoid arthritis (Richardson, 2002; Gowers et al.,
2011; Karouzakis et al., 2011). As T cells age and acquire a more
autoreactive phenotype, it is reasonable to assume that the body
responds by increased production of Tregs to prevent autoimmunity. Key
regulatory elements upstream of the FoxP3 gene are sensitive to DNA
methylation (Lal & Bromberg, 2009). We demonstrated that FoxP3
expression increases in aged T cells at the RNA and protein level and
coincides with an increase in the Tregs population in the proportion to
total CD4+ T cells. We also demonstrated for the first time that increased
FoxP3 expression is accompanied by demethylation of the FoxP3
upstream enhancer. We posit that the aging-associated DNA hypome-
thylation-driven increase in FoxP3 expression constitutes a strategy for
keeping autoimmunity in check as organisms age.
While conferring benefit in ameliorating autoimmunity, a higher Treg
population could enhance age-related immune senescence. Classic
senescence in CD4 cells features the loss of expression of CD28
costimulatory molecule in addition to shorter telomere length (Effros,
1997) and decreased production and use of IL-2 (Nagel et al., 1988). In
mice, the pool of CD45RA+ na€ıve T cells decreases due to thymic
involution (Nikolich-Zugich, 2008), while the CD45RO+ memory com-
partment and Tregs increase with aging (Han et al., 2009). Immunose-
nescence can lead to poor response to pathogens and tumors (Cannizzo
et al., 2011). Tregs can promote the immunosenescent phenotype both
via interactions with Teff cells and by inhibition of the APC/Teff
interaction (Vignali et al., 2008). DCs activate Teff cells through
engagement of CD3 receptor with the MHCII/antigen complex and
CD28 with costimulatory molecules CD80 and CD86. Interestingly,
exposure of DCs to hypomethylated DNA collected from aged individuals
enhances expression of costimulatory molecules CD80 and CD86
(Agrawal et al., 2010). We find that Tregs from aged animals, whose
greater numbers may be attributable to hypomethylation of the FoxP3
enhancer, are more effective at interfering with DC/Teff costimulation by
downregulation of CD86. Tregs reportedly limit CD86 expression, but
not CD80 on DCs via secretion of IL-10 (Slavik et al., 1999; Cederbom
et al., 2000), an observation that we have confirmed. This is consistent
with increased IL-10 secretion by Tregs from aged mice effectively
suppressing Teff expansion in vitro.
Cytokines play a key role in both activation and suppression of T-cell
proliferation. Tregs can deplete IL-2 via CD25HI expression and release
suppressor cytokines TGF-b and IL-35 in addition to IL-10 (Shevach,
2009). While we did not find a difference in IL-2 concentrations available
in DC/Teff/Treg cocultures (data not shown), we found a significant
increase in extracellular IL-10 concentration in the presence of Tregs
from aged mice. A similar increase in IL-10 was observed during
coculture of CD4+ CD25 T cells with aged Tregs in the absence of DCs,
suggesting that the greater IL-10 release is not dependent on the
presence of DCs. Different subsets of Tregs can mediate suppression in
different ways, depending on the microenvironment. For example, IL-10
is particularly associated with Tregs that suppress Th17 proliferation (Tian
et al., 2012). Whether the observed increase in IL-10 secretion by Tregs
from old mice indicates a shift in Treg subset populations as part of the
aging process, is an intriguing question that remains to be examined.
T-cell activation and proliferation requires a reducing extracellular
microenvironment (Angelini et al., 2002). Tregs create conditions that
are less favorable for Teff proliferation by decreasing DC-derived
extracellular cysteine, which inhibits Teff GSH synthesis, thereby inter-
fering with DNA synthesis necessary for clonal expansion (Yan et al.,
2009, 2010). Tregs from both young and old mice deprive Teffs of
extracellular cysteine, raising the redox potential. Our studies reveal that
aged Tregs are more effective at inhibiting cystine metabolism by DCs in
comparison with young Tregs. The perturbed cysteine/cystine redox
potential resulting from higher Treg activity, leads to lower GSH
synthesis in Teffs, which in turn lowers their proliferative potential.
Greater Treg-mediated redox perturbation might be an important
contributing mechanism for immune senescence in the elderly. We
have also tested the significance of redox potential by performing
suppression assays in the presence of N-acetylcysteine (NAC). NAC
supplementation provides additional precursors to glutathione synthesis,
enhancing seceretion of cysteine via the c- glutamyl pathway. This
pathway allows provision of cysteine into the extracellular environment,
which creates a more favorable redox environment for proliferation.
Similar to anti-IL-10 antibody, NAC partially alleviate the Treg-mediated
suppression by young and old Tregs. These data suggest that NAC is
playing a role in the increased regulatory function of old Tregs. As there
are several mechanisms of Treg-mediated suppression of T-cell prolifer-
ation, it is not surprising that neither IL-10 neutralization nor NAC by
itself can fully prevent suppression.
In summary, our findings suggest that Tregs from aged mice have
greater suppressive capability than Tregs from young mice. Aged Tregs
exercise greater suppression through multiple known mechanisms of
action against both DCs and effector T cells. These mechanisms include
downregulation of CD86 on DCs, greater release of IL-10, and lowering
of the proliferative potential of Teffs via modulation of the redox
microenvironment (Supplementary Fig. 1). Increased total numbers of
Tregs in aged animals is associated with demethylation of the FoxP3
enhancer region, suggesting a role for DNA hypomethylation with
acquisition of a regulatory phenotype, which may have evolved to
protect against hypomethylation-induced T-cell autoreactivity. Taken
together, these data suggest that an increased Treg compartment with
heightened suppressive function may be an important player in the onset
of immune senescence during aging.
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Fig. S1. A model for age-associated higher activity of Tregs.
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